Filing Details

Accession Number:
0000904454-10-000475
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-01 09:49:58
Reporting Period:
2010-11-29
Filing Date:
2010-12-01
Accepted Time:
2010-12-01 09:49:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1375151 Zogenix Inc. ZGNX Pharmaceutical Preparations (2834) 205300780
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1372932 Dp Vii Associates Lp C/o Domain Associates, Llc
One Palmer Square
Princeton NJ 08542
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-29 35,215 $0.00 35,215 No 4 C Direct
Common Stock Acquisiton 2010-11-29 21,027 $0.00 56,242 No 4 C Direct
Common Stock Acquisiton 2010-11-29 14,903 $0.00 71,145 No 4 C Direct
Common Stock Acquisiton 2010-11-29 39,410 $4.00 110,555 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-1 Preferred Stock Disposition 2010-11-29 35,215 $0.00 35,215 $0.00
Common Stock Series B Preferred Stock Disposition 2010-11-29 21,027 $0.00 21,027 $0.00
Common Stock Convertible Promissory Notes Disposition 2010-11-29 14,903 $0.00 14,903 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. All outstanding shares of the Issuer's preferred stock were automatically converted into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration.
  2. All Convertible Promissory Notes, plus interest accrued thereon through the closing of the IPO, automatically converted into Common Stock upon the closing of the IPO, based on the IPO price of $4.00 per share.